In gliomas, FGFR overexpression or gene fusion events, notably the FGFR3-tyransforming acidic crimp 3 (TACC3) fusion, can aberrantly activate these downstream pathways, promoting tumor cells proliferation, migration, and invasion (Singh et al., 2012). The gene discussed is FGFR3; the disease is neoplasm.